Polymer nano-systems for the encapsulation and delivery of active biomacromolecular therapeutic agents
M Machtakova, H Thérien-Aubin… - Chemical society …, 2022 - pubs.rsc.org
Biomacromolecular therapeutic agents, particularly proteins, antigens, enzymes, and nucleic
acids are emerging as powerful candidates for the treatment of various diseases and the …
acids are emerging as powerful candidates for the treatment of various diseases and the …
The role of CD44 in cancer chemoresistance: A concise review
CD44 is a cell surface adhesion molecule, which is overexpressed on cancer stem cells.
The interaction of CD44 with hyaluronan is responsible for tumor development, metastasis …
The interaction of CD44 with hyaluronan is responsible for tumor development, metastasis …
BACH1, the master regulator gene: A novel candidate target for cancer therapy
Abstract BACH1 (BTB and CNC homology 1, basic leucine zipper transcription factor 1) is a
transcriptional factor and a member of cap 'n'collar (CNC) and basic region leucine zipper …
transcriptional factor and a member of cap 'n'collar (CNC) and basic region leucine zipper …
[HTML][HTML] Effect of molecular weight of chitosan on the physicochemical, morphological, and biological properties of polyplex nanoparticles intended for gene delivery
ME Aranda-Barradas, SE Trejo-López… - Carbohydrate polymer …, 2022 - Elsevier
The use of viral vectors in gene therapy has many disadvantages that have been widely
described. The development of new nonviral vectors using safe polymers such as chitosan …
described. The development of new nonviral vectors using safe polymers such as chitosan …
The characteristics and improved intestinal permeability of vancomycin PLGA-nanoparticles as colloidal drug delivery system
P Zakeri-Milani, BD Loveymi, M Jelvehgari… - Colloids and Surfaces B …, 2013 - Elsevier
AIM: In the present investigation, vancomycin (VCM) biodegradable nanoparticles were
developed for oral administration, with the aim of improving its intestinal permeability …
developed for oral administration, with the aim of improving its intestinal permeability …
From oncogenic signaling pathways to single-cell sequencing of immune cells: changing the landscape of cancer immunotherapy
Over the past decade, there have been remarkable advances in understanding the signaling
pathways involved in cancer development. It is well-established that cancer is caused by the …
pathways involved in cancer development. It is well-established that cancer is caused by the …
Chitosan-nanoconjugated hormone nanoparticles for sustained surge of gonadotropins and enhanced reproductive output in female fish
A controlled release delivery system helps to overcome the problem of short life of the
leutinizing hormone releasing hormone (LHRH) in blood and avoids use of multiple …
leutinizing hormone releasing hormone (LHRH) in blood and avoids use of multiple …
Design of experiments to achieve an efficient chitosan-based DNA vaccine delivery system
C Rodolfo, D Eusébio, C Ventura, R Nunes… - Pharmaceutics, 2021 - mdpi.com
In current times, DNA vaccines are seen as a promising approach to treat and prevent
diseases, such as virus infections and cancer. Aiming at the production of a functional and …
diseases, such as virus infections and cancer. Aiming at the production of a functional and …
Lipid-and polymer-based plexes as therapeutic carriers for bioactive molecules
P Shende, N Ture, RS Gaud, F Trotta - International Journal of …, 2019 - Elsevier
Recently, promising strategies of plexes include the complexation of nucleic acids with lipids
(lipoplexes) and different kinds of polymers (polyplexes) for delivery of actives and genetic …
(lipoplexes) and different kinds of polymers (polyplexes) for delivery of actives and genetic …
Overcoming the challenges of siRNA delivery: nanoparticle strategies
Background: Despite therapeutics based on siRNA have an immense potential for the
treatment of incurable diseases such as cancers. However, the in vivo utilization of siRNA …
treatment of incurable diseases such as cancers. However, the in vivo utilization of siRNA …